Changzhou Qianhong Biopharma Co Ltd (002550) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.057x

Based on the latest financial reports, Changzhou Qianhong Biopharma Co Ltd (002550) has a cash flow conversion efficiency ratio of 0.057x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥156.34 Million ≈ $22.88 Million USD) by net assets (CN¥2.76 Billion ≈ $403.82 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Changzhou Qianhong Biopharma Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2024)

This chart illustrates how Changzhou Qianhong Biopharma Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Changzhou Qianhong Biopharma Co Ltd carry for a breakdown of total debt and financial obligations.

Changzhou Qianhong Biopharma Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Changzhou Qianhong Biopharma Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Afry AB ST:AFRY	0.105x
Grupo Aeroméxico S.A.B. de C.V MX:AEROMEX	-0.311x
Sino Medical Sciences Technology In SHG:688108	0.034x
Jupiter Wagons Limited NSE:JWL	0.005x
Couchbase Inc NASDAQ:BASE	-0.028x
Dogan Sirketler Grubu Holding AS IS:DOHOL	0.116x
Novavax Inc NASDAQ:NVAX	0.309x
Labrador Iron Ore Royalty Corp TO:LIF	0.051x

Annual Cash Flow Conversion Efficiency for Changzhou Qianhong Biopharma Co Ltd (2007–2024)

The table below shows the annual cash flow conversion efficiency of Changzhou Qianhong Biopharma Co Ltd from 2007 to 2024. For the full company profile with market capitalisation and key ratios, see Changzhou Qianhong Biopharma Co Ltd market cap and net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥2.52 Billion ≈ $368.25 Million	CN¥514.71 Million ≈ $75.32 Million	0.205x	-5.13%
2023-12-31	CN¥2.47 Billion ≈ $362.01 Million	CN¥533.33 Million ≈ $78.04 Million	0.216x	+833.97%
2022-12-31	CN¥2.43 Billion ≈ $356.08 Million	CN¥-71.47 Million ≈ $-10.46 Million	-0.029x	-160.08%
2021-12-31	CN¥2.12 Billion ≈ $309.95 Million	CN¥103.56 Million ≈ $15.15 Million	0.049x	-68.17%
2020-12-31	CN¥2.07 Billion ≈ $302.24 Million	CN¥317.28 Million ≈ $46.43 Million	0.154x	+121.81%
2019-12-31	CN¥2.33 Billion ≈ $341.34 Million	CN¥161.55 Million ≈ $23.64 Million	0.069x	+590.82%
2018-12-31	CN¥2.54 Billion ≈ $371.42 Million	CN¥25.45 Million ≈ $3.72 Million	0.010x	-72.22%
2017-12-31	CN¥2.45 Billion ≈ $358.94 Million	CN¥88.52 Million ≈ $12.95 Million	0.036x	-60.41%
2016-12-31	CN¥2.42 Billion ≈ $354.79 Million	CN¥221.01 Million ≈ $32.34 Million	0.091x	-27.00%
2015-12-31	CN¥2.29 Billion ≈ $335.75 Million	CN¥286.50 Million ≈ $41.92 Million	0.125x	+5.67%
2014-12-31	CN¥2.13 Billion ≈ $312.08 Million	CN¥252.01 Million ≈ $36.88 Million	0.118x	+45.10%
2013-12-31	CN¥1.97 Billion ≈ $288.35 Million	CN¥160.47 Million ≈ $23.48 Million	0.081x	-23.84%
2012-12-31	CN¥1.87 Billion ≈ $273.47 Million	CN¥199.82 Million ≈ $29.24 Million	0.107x	+28.62%
2011-12-31	CN¥1.77 Billion ≈ $258.44 Million	CN¥146.82 Million ≈ $21.48 Million	0.083x	-79.94%
2010-12-31	CN¥413.78 Million ≈ $60.55 Million	CN¥171.51 Million ≈ $25.10 Million	0.415x	+1109.63%
2009-12-31	CN¥243.68 Million ≈ $35.66 Million	CN¥8.35 Million ≈ $1.22 Million	0.034x	-86.26%
2008-12-31	CN¥217.99 Million ≈ $31.90 Million	CN¥54.36 Million ≈ $7.95 Million	0.249x	+46.60%
2007-12-31	CN¥211.61 Million ≈ $30.97 Million	CN¥35.99 Million ≈ $5.27 Million	0.170x	--

About Changzhou Qianhong Biopharma Co Ltd

SHE:002550 China Drug Manufacturers - Specialty & Generic

Market Cap

$1.31 Billion

CN¥8.96 Billion CNY

Market Cap Rank

#7946 Global

#1986 in China

Share Price

CN¥7.00

Change (1 day)

-1.27%

52-Week Range

CN¥5.95 - CN¥12.27

All Time High

CN¥12.27